Latest DEF 14A proxy statements

Team, Inc. has announced its 2026 Annual Meeting of Shareholders, set for May 20, 2026, to vote on director elections, executive compensation, and key corporate proposals.

Credit Acceptance Corporation has filed its 2026 Proxy Statement detailing the upcoming Annual Meeting of Shareholders on June 10, 2026, focusing on director elections, executive compensation, and auditor ratification.

Chipotle Mexican Grill outlines its 'Recipe for Growth' strategy, focusing on operational excellence, menu innovation, technology modernization, global expansion, and talent development, while detailing director nominees and executive compensation.

FirstCash Holdings, Inc. has announced its 2026 Annual Meeting of Stockholders, set for June 9, 2026, to elect directors, ratify auditors, and vote on a proposed reincorporation to Texas.

Hims & Hers Health, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for June 11, 2026, to be held virtually.

Verde Clean Fuels, Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders, scheduled for June 12, 2026, to elect a director and ratify its auditor.

Schrodinger, Inc. announced its 2026 Annual Meeting of Stockholders, scheduled for June 22, 2026, to vote on director elections, executive compensation, and equity plan amendments.

Cartesian Therapeutics, Inc. has announced its 2026 Annual Meeting of Stockholders will be held virtually on June 12, 2026, to elect directors, approve executive compensation, and ratify auditor appointments.

Cabaletta Bio, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for June 9, 2026, to elect directors, ratify auditors, and vote on key corporate actions including a significant increase in authorized shares.

Zai Lab Limited has issued its proxy statement for the 2026 Annual General Meeting of Shareholders, detailing proposals for director re-elections, auditor appointments, and share mandates.

Ocugen provides an update on its gene therapy programs, clinical trial progress, and upcoming annual meeting of stockholders.

Cullinan Therapeutics, Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders, scheduled for June 16, 2026, to elect directors, ratify auditors, and vote on executive compensation.

Hut 8 Corp. has issued its proxy statement for the 2026 Annual Meeting of Stockholders, scheduled for June 11, 2026, detailing proposals for director elections, executive compensation, auditor ratification, and incentive plan amendments.

Universal Health Realty Income Trust announces its 2026 Annual Meeting of Shareholders, scheduled for June 10, 2026, featuring virtual attendance and key votes on trustee elections, executive compensation, and auditor ratification.

Security National Financial Corporation announces its 2026 Annual Meeting of Stockholders, detailing proposals for director elections, equity plan amendments, executive compensation, and auditor ratification.

Revolution Medicines has issued its 2026 proxy statement detailing director elections, auditor ratification, and executive compensation advisory votes.

GameSquare Holdings, Inc. has scheduled its 2026 Annual Meeting to vote on board elections, auditor ratification, and a merger to modernize corporate governance.

Patriot National Bancorp announces its 2026 Annual Meeting, seeking shareholder approval for a reverse stock split and director elections.

Exagen Inc. has released its 2026 proxy statement detailing the upcoming annual meeting agenda, director elections, and executive compensation.

Fusemachines Inc. has issued its 2026 proxy statement detailing the upcoming annual meeting, including director elections and an equity incentive plan amendment.

Ovid Therapeutics Inc. has filed its definitive proxy statement for the 2026 Annual Meeting of Stockholders to be held virtually on June 10, 2026.

Alight, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for June 10, 2026, and is proposing several amendments to its Charter, including declassifying the board, providing officer exculpation, and authorizing reverse stock splits.

LendingTree's 2026 proxy statement outlines the upcoming annual meeting, board elections, and executive compensation following the passing of founder and CEO Doug Lebda.

DigitalBridge Group, Inc. files its 2026 proxy statement ahead of its annual meeting, seeking approval for director elections, executive compensation, and an amendment to its 2024 Omnibus Stock Incentive Plan.

Ascent Solar Technologies, Inc. has issued its 2026 proxy statement detailing proposals for its upcoming annual meeting on June 17, 2026.

Metagenomi Therapeutics, Inc. has scheduled its 2026 Annual Meeting of Stockholders for June 9, 2026, to conduct routine director elections and auditor ratification.

Brilliant Earth Group, Inc. has issued its 2026 proxy statement detailing the upcoming virtual annual meeting, director elections, and auditor ratification.

Century Therapeutics has filed its 2026 proxy statement, outlining director elections, auditor ratification, and a proposal to increase authorized common stock.

Atea Pharmaceuticals announces its 2026 Annual Meeting of Stockholders, focusing on director elections, executive compensation, and clinical pipeline progress.

Quince Therapeutics announces its 2026 Annual Meeting, seeking shareholder approval for a reverse stock split to maintain Nasdaq compliance.